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ABSTRACT: Akt1 is a serine/threonine kinase that promotes cell growth and survival.
Previously, Akt1 activation in a double transgenic (DTG) mouse model fed a high-fat/high-
sucrose (HF/HS) diet was found to promote type IIb muscle growth and to lead to a
signiﬁcant reduction in obesity. Here, we have used metabolomics to examine the metabolic
perturbations in blood serum and liver and gastrocnemius tissues of the DTG mice.
Multivariate statistics highlighted consistent metabolic changes in gastrocnemius muscle
following Akt1 activation, which included signiﬁcant reductions of serine and histidine-
containing dipeptides (anserine and carnosine), in addition to increased concentrations of
phosphorylated sugars. In addition, Akt1-mediated regression in obesity could be associated
with increased glycolysis in gastrocnemius muscle as well as increased gluconeogenesis,
glycogenolysis, and ketogenesis in the liver. In old DTG animals, Akt1 activation was found to
improve glucose metabolism and confer a beneﬁcial eﬀect in the regression of age-related fat
accumulation. This study identiﬁes metabolic changes induced by Akt1-mediated muscle
growth and demonstrates a cross-talk between distant organs that leads to a regression of fat
mass. The current ﬁndings indicate that agents that promote Akt1 induction in muscle have utility in the regression of obesity.
KEYWORDS: Protein kinase B, metabonomics, obesity, type 2 diabetes
■ INTRODUCTION
Akt, or protein kinase B, is a protein from the serine/threonine
kinase family that is involved in signaling during cell growth and
proliferation, apoptosis, transcription, angiogenesis, migration,
and glucose metabolism.1−4 Increased Akt activity has been
found in numerous cancer types, but the loss of Akt activation has
been associated with the development of type-2 diabetes,
suggesting that the Akt pathway is an attractive therapeutic
target for these diseases.2−4 Akt is a downstream component in
phosphoinositide 3-kinase (PI3K) signaling, and it is activated by
a wide range of stimuli, including insulin and insulin-like growth
factor.1 The downstream kinase targets of Akt include glycogen
synthase kinase 3, mammalian target of rapamycin (mTOR),
p70S6K, PHAS-1 (4EBP-1), and the Foxo family, demonstrating
the important role Akt plays in regulating metabolism.5
To date, three Akt isoforms have been identiﬁed in mammals,
namely, Akt1, Akt2, and Akt3 (also known as PKBα, PKBβ,
PKBγ, respectively).4 Akt1 is known to be involved in cell
growth, but recent studies have also demonstrated its role in
energy metabolism, suggesting that it is a potential target in
treating obesity.6,7 Previously, we have described a double
transgenic (DTG) mouse model with inducible Akt1 expression
in skeletal muscle.6,8 Muscle-speciﬁc Akt1 overexpression was
found to selectively induce type IIbmuscle hypertrophy, improve
insulin sensitivity, and cause reductions in fat mass and
blood glucose concentration. In addition, transcriptomics
indicated increased glycolysis in the gastrocnemius muscle as
well as upregulated gluconeogenesis and ketogenesis in the liver
of the DTG animals.
In the current study, we have used a combination of pro-
ton nuclear magnetic resonance (1H NMR) spectroscopy, gas
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chromatography−mass spectrometry (GC−MS), GC with a
ﬂame ionization detector (GC−FID), and liquid chromatography−
mass spectrometry (LC−MS) to investigate the metabolic
perturbations in blood serum and liver and gastrocnemius tissues
of the DTG mice. We then placed these metabolic changes in
the context of Akt1 induction and the subsequent conferred
metabolic advantage in terms of reducing obesity and reducing
insulin resistance in aged animals. Our results identiﬁed path-
ways that were perturbed by Akt1 activation, leading to
regression of diet-induced obesity and improvement of age-
related fat accumulation. In addition, a metabolomic study of the
gastrocnemius muscle identiﬁed a metabolic signature of Akt1
overexpression, which was also observed inmodels of obesity and
advanced age.
■ MATERIAL AND METHODS
Animals and Experimental Design
The generation of a skeletal muscle-speciﬁc, inducible Akt1 DTG
mouse model has been previously described in detail.6 In brief,
1256 [3Emut] MCK-rtTA transgenic mice9 were crossed with
TRE-myrAkt1 transgenic mice10 to produce the DTG mouse
model. In the current study, 1256 [3Emut] MCK-rtTA single
transgenic mice were used as controls. All protocols were
approved by the BostonUniversity Institutional Animal Care and
Use Committee.
Two studies were conducted to examine the eﬀect of a high-
fat/high-sucrose (HF/HS) diet and aging on Akt1 activation in
the DTG mice. In the study on the eﬀect of diet, 12-week old
male controls and DTG mice were fed either a standard chow
(Harlan Teklad global 18% protein rodent diet, no. 2018) or
HF/HS (Bio-Serv, no. F1850) diet for 3months (12 weeks; n = 6
for each group). Doxycycline was administered through the
drinking water to all animals fromweeks 9−12 of the experiment,
which caused a muscle-speciﬁc Akt1 induction in the DTG mice
but not in the single transgenic controls. Blood serum samples
were collected before and after doxycycline administration (at
weeks 8 and 12), while gastrocnemius muscle and liver tissues
were collected at 3 months.
In the second study, which focused on the eﬀect of aging, the
male single transgenic controls and DTG mice (3 and 18 months
old)were fed the chowdiet togetherwith doxycycline administration
for 4 weeks (n = 6 for each group) before the samples (serum,
gastrocnemius muscle, and liver tissue) were collected. All
sampleswere stored at−80 °Cuntil further analysis bymetabolomics.
Metabolic Proﬁling Using 1H NMR Spectroscopy
Blood serum was analyzed using a two-tube NMR system, where
sodium-3-(trimethylsilyl)-2,2,3,3-tetradeuteriopropionate
(TSP) was used as chemical shift standard.11 Eighty microliters
of blood serum was loaded into a capillary tube (1.7 mm o.d.)
(New Era, Vineland, NJ, USA), which was then inserted into an
outer 5 mmNMR tube containing 600 μL of D2O with 0.9% w/v
sodium chloride and 0.1 mM TSP (Cambridge Isotope
Laboratories Inc., Andover, MA, USA) and then subsequently
analyzed. For tissues, metabolites were extracted using
methanol/chloroform/water extraction.12,13 In detail, frozen
tissues (∼20 mg for gastrocnemius muscle and ∼40 mg for liver
tissue) were ﬁrst transferred into microcentrifuge tubes (Starlab,
UK). Then, a stainless steel bead was added to each tube,
followed by 600 μL of chloroform/methanol (2:1) (both from
Sigma-Aldrich). Tissues were then homogenized using a
TissueLyser (Qiagen, UK), and the resulting homogenates
were sonicated for 15 min. The stainless steel beads were
removed, and chloroform and water (200 μL of each) were
added to each tube before the samples were centrifuged at
13 300 rpm for 10 min. After that, the aqueous and organic
phases were separated from the protein pellets. The aqueous
phase was dried using an evacuated centrifuge (Eppendorf,
Hamburg, Germany), while the organic phase was evaporated to
dryness in a fume hood. All dried samples were stored at −80 °C
until further analysis. Prior to 1H NMR analysis, dried tissue
extracts were dissolved in 600 μL of D2O containing TSP (0.5
mM for the extracts of liver tissue or 0.2 mM for the extracts of
gastrocnemius muscle) and sodium azide (∼0.1% w/v).
The blood serum and tissue extracts were analyzed by 1H
NMR spectroscopy at 500 MHz at 300 K for tissue extracts and
at 310 K for blood serum, using a solvent suppression pulse
sequence based on a one-dimensional NOESY pulse sequence.
The NMR spectra were processed using ACD SpecManager 1D
NMR processor (version 8, ACD, Toronto, Canada). Spectra
were Fourier-transformed, referenced to TSP at 0.0 ppm, and
were phased and baseline-corrected manually. Each spectrum
was integrated using 0.02 ppm integral regions between 0.2 and
10.0 ppm for tissue spectra and −0.04 and 10.0 ppm for serum
spectra. The water-containing region (4.7−4.8 ppm for tissue
spectra and 4.5−5.0 ppm for serum spectra) was excluded from
further analysis. Each integral region of blood serum NMR
spectra was normalized to the integral value of TSP for each
spectrum. To account for any diﬀerence in concentration
between tissue samples, each spectral region was normalized to
a total integral value of 1. All NMR peaks were assigned on the
basis of theHumanMetabolome database14 (http://www.hmdb.ca),
published literature,15 Chenomx NMR suite version 5.1 (Chenomx,
Alberta, Canada), or by the use of authentic standards.
Metabolic Proﬁling Using Gas Chromatography
Prior to GC−MS analysis, L-proline (U-13C5, 98%), L-glutamic
acid (U-13C5, 98%;
15N, 98%), and myristic acid (1,2,3-13C3,
99%) (Cambridge Isotope Laboratories Inc., Andover, MA,
USA) were added to the aqueous soluble metabolites as internal
standards, and the sample was dried using an evacuated
centrifuge (Eppendorf, Hamburg, Germany). The dried samples
were then derivatized using a two-step procedure.16 First, the
samples were methoxymated using 30 μL of methoxyamine
hydrochloride (20 mg/mL in pyridine; Sigma-Aldrich Ltd.,
Dorset, UK) for 17 h. Then, the samples were silylated using
30 μL of N-methyl-N-trimethylsilyltriﬂuoroacetamide (MSTFA;
Macherey-Nagel, Duren, Germany) for 1 h at room temperature.
The derivatized samples were then diluted with hexane (200 μL
ﬁnal volume) and analyzed using a Trace GC Ultra coupled to a
DSQ II single-quadrupole mass spectrometer (ThermoScientiﬁc,
Hemel Hempstead, UK). The column used was 5% polysilarylene,
95% polydimethylsiloxane (30 and 0.25 mm i.d.) (Phenomenex,
Macclesﬁeld, Cheshire, UK). During data acquisition, the temper-
ature was ramped from 70 to 310 °C in a 35 min period. The
resulting mass spectra were matched to the National Institute of
Standards and Technology (NIST) library. Overlapping peaks were
deconvoluted using traces of selected ions.
To proﬁle the total fatty acid complement of blood plasma and
the tissue extracts, organic soluble metabolites were derivatized
using an acid-catalyzed esteriﬁcation procedure.17 Speciﬁcally,
dried organic soluble metabolites were dissolved in 750 μL
of chloroform/methanol (1:1) and transferred into a glass
vial. Then, 250 μL of boron triﬂuoride (BF3; 10% in methanol;
Sigma-Aldrich) was added, and the samples were incubated at
80 °C for 90 min. The derivatized samples were then analyzed
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using a Focus GC, and the column eluent was introduced into a
ﬂame-ionization detector (FID, Thermo Electron Corporation).
The column used was a TR-FAME column (30 m× 0.25mm i.d.)
with a 70% cyanopropyl polysilphenylene-siloxane stationary
phase (ThermoScientiﬁc). During the experiment, the temper-
ature was ramped from 55 to 230 °C in a 28 min run. Assignment
of organic phase metabolites was carried out by comparison with a
FAME standard mix (Supelco 37 Component FAMEMix; Sigma-
Aldrich) and mass spectrometry where necessary.
For both aqueous and organic phase metabolites analysis, the
GC chromatograms were processed using Xcalibur (version 2.0;
ThermoScientiﬁc), in which each individual peak was integrated
manually and then normalized to the internal standard peak(s).
Lipidomics by Liquid Chromatography−Mass Spectrometry
Analysis was performed using a Waters Xevo G2 quadrupole
time-of-ﬂight mass spectrometer (Waters Ltd., Hertfordshire,
UK) with an electrospray ionization probe and a Z-spray ion
source. The spectrometer was coupled to a Waters Acquity
UPLC system.
One-ﬁfth of the organic fractions of gastrocnemius and liver
tissue was dissolved in 100 μL of 1:1 methanol/chloroform. The
resulting lipid solution was further diluted with 900 μL of 2:1:1
iso-propanol/acetonitrile/water containing 20 μM phosphoti-
dylcholine (PC 34:0) (Avanti Polar Lipids, CA, USA) as an
internal standard and placed inside a 1.5 mL glass screwtop vial
(Agilent, Santa Clara, CA, USA) and capped for analysis. Ten
microliters of each sample was combined into a new vial and used
as a pool sample for quality control and analyte identiﬁcation. All
analyses were conducted using a method utilizing simultaneous
low- and high-energy mass scan functions in both negative and
positive ionization modes to provide fragmentation data for lipid
identiﬁcation. Both functions used a centroid full scan from
50 m/z to 1200 m/z with a capillary voltage and cone voltage of
3.0 kV and 30 V for positive ion mode and 2.5 kV and 25 V for
negative ion mode, respectively. Compounds were separated
using a CSH C18 column (2.1 mm × 100 mm, 1.7 μm; Waters
Ltd., Hertfordshire, UK). Mobile phase A consisted of 10 mM
ammonium formate in 3:2 acetonitile/water, and mobile phase B
consisted of 10 mM ammonium formate in 9:1 iso-propanol/
acetonitrile. The chromatography gradient was as follows: a
linear gradient of 40 to 43% B over 2.0 min followed by an
increase to 50% B over 0.1 min and then to 54% until 12.0 min.
The composition of B was then increased to 70% over the
following 0.1 min and further increased to 99% until 18 min, at
which time the column was equilibrated for 2 min to give a total
run time of 20 min. The ﬂow rate was 400 μL/min, and the
column temperature was 55 °C. The injection volume was 5 μL.
Data were processed using MarkerLynx within the software
suit Masslynx (version 1.4) by Waters Ltd. (Herfordshire, UK).
Peak areas were collated and normalized in Excel (Microsoft).
All spectral peak areas were normalized against the total area
of all peaks within a sample. Lipid species were identiﬁed by
fragmentation data obtained from the high-energy function
described above and compared with online databases (e.g., www.
lipidmaps.org).
Statistical Data Analysis
Data sets were imported into SIMCA-P+ 11.0 (Umetrics, Umea,̊
Sweden) for processing using principal components analysis
(PCA), partial least-squares (PLS) analysis, and PLS-discrim-
inant analysis (PLS-DA) (a regression extension of PCA used
for classiﬁcation). Prior to multivariate analysis, the NMR and
LC−MS data sets were mean-centered and Pareto-scaled, while
the GC−MS and GC−FID data sets were mean-centered and
scaled to unit variance. Pareto scaling weights each variable with
the square root of its standard deviation and therefore increases
the weighting of low-intensity metabolites while at the same time
limiting the inﬂuence of noise on the multivariate model. Unit
variance scaling weights each variable with its standard deviation,
and the resulting model is not biased toward high-concentration
metabolites.
The Q2 and R2 values from the resulting multivariate model
were used to assess the robustness of a model, where R2 shows
the fraction of variation explained by a component, and Q2
shows the predictability of the model through cross-validation.
Typically, a robust model has a Q2 > 40%. In addition, these
models were assessed for robustness using the validation tool
within SIMCA that assesses theQ2 and R2 for each model against
models produced, where the Y value for class membership has
been permuted to produce randommodels. Here, a robust model
is represented by Q2actual ≫ Q2random.
Identiﬁcation of major metabolic perturbations within the
pattern recognition models was achieved by analysis of cor-
responding loadings plots. In addition, the diﬀerential metabo-
lites found were conﬁrmed by standard univariate tests (for
example, Student’s t-test).
■ RESULTS
Akt1-Induced Muscle Hypertrophy Reduced Both
Diet-Induced and Age-Related Fat Accumulation
To place our subsequent metabolomics studies in a physiological
context, we ﬁrst investigated the eﬀect of Akt1 overexpression on
diet-induced obesity. Twelve-week old mice were fed either a
normal chow or HF/HS diet for 8 weeks before Akt1 gene
induction. TheHF/HS diet caused an increase in body weight for
both the controls and DTG mice (Figure 1A). As previously
reported, the overall weight gain was signiﬁcantly less in the DTG
animals following 4 weeks of Akt1 activation (p < 0.05), whereby
the controls showed a further increasing trend in body weight
(Figure 1A). In contrast, Akt1 gene induction had no eﬀect on
body weight for mice fed a normal chow diet.
Next, we examined the eﬀect of Akt1 overexpression on the
weight of tissues in the same animals after 4 weeks of Akt1
activation. Akt1 induction caused a 34.8% increase in gastro-
cnemius muscle weight, and the extent of muscle growth did not
depend on the dietary conditions used in the current study
(Figure 1B, right). Compared with HF/HS-fed controls, the
inguinal and subcutaneous fat masses of the HF/HS-fed DTG
mice were 49.0 and 59.7% lower, respectively (Figure 1B, left
and middle, p < 0.01). Similarly, the DTG mice fed the normal
diet also showed a reduction in inguinal fat mass, but to a lesser
extent.
To investigate the eﬀect of aging on Akt1-mediated muscle
hypertrophy, we next studied chow-fed controls and DTG mice
at two diﬀerent age groups (12 weeks and 18 months). Notably,
in old animals, the extent of Akt1-induced muscle hypertrophy
was found to be signiﬁcantly less than that in the young animals
(Figure 1C, right; P = 0.0075). In addition, aging led to fat
accumulation in the old animals (Figure 1C, left andmiddle), and
the data in the current study showed that this could be improved
by Akt1 activation. As compared with the controls, the inguinal
and subcutaneous fat of the old DTG animals were found to be
33.3 and 32.3% lower, respectively. The age-related fat accumula-
tion was balanced by a decreased weight of muscle and probably
other tissues, as no signiﬁcant diﬀerence in total body weight was
Journal of Proteome Research Article
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observed for all four studied groups in the aging study
(Supporting Information Figure S1).
Metabolic Signature of AKT1-Induced Muscle Hypertrophy
Analysis of 1H NMR data of gastrocnemius muscle (n = 48 for
the total number of animals, including data from both diet and
aging studies) using unsupervised PCA shows clustering of
samples based on induced genotype (Supporting Information
Figure S2). The result indicated that Akt1 induction is the major
source of metabolic variation, suggesting potential metabolic
markers for Akt1-induced muscle hypertrophy.
To further deﬁne these metabolic changes, the data were
analyzed using PLS-DA to assess the discrimination between
the single transgenic controls and DTG mice. This supervised
analysis produced a robust two-component model (Figure 2A),
which was validated using a permutation test within SIMCA P+
(Figure 2B). The most discriminatory compounds identiﬁed by
the analysis were anserine and carnosine (assigned by the spiking
Figure 1. Obesity induced by a high-fat/high-sucrose diet could be regressed by Akt1 induction (A). The corresponding changes in tissue weight (B).
Akt1 induction also conferred a reduction in age-related fat accumulation (C).
Journal of Proteome Research Article
dx.doi.org/10.1021/pr500756u | J. Proteome Res. 2015, 14, 342−352345
of authentic anserine and carnosine standards, Supporting
Information Figure S3). After 4 weeks of Akt1 activation, there
was a 39.2% average reduction in anserine (t test, P = 2.55 ×
10−13) and 50.9% reduction in the carnosine/anserine multiplets
(t test, P = 3.28 × 10−16) (Figure 2C,D). Analysis of an addi-
tional spectral region (7.00−7.25 ppm) where anserine and
carnosine are coresonant also showed a reduction of 50.7%
(t test, P = 2.34 × 10−17) following Akt1 activation. This result
indicated that both anserine and its precursor, carnosine, were
reduced by Akt transgene induction inmuscle, both in young and
old mice and when mice are fed either a normal or HF/HS diet.
The aqueous metabolites in the gastrocnemius muscle were
also proﬁled using a complementary GC−MS method. Analysis
by PLS-DA further identiﬁed signiﬁcant reductions in inorganic
Figure 2. PLS-DA scores plot of the NMR spectra of gastrocnemius muscle tissue show separation between the controls (black squares) and DTG (red
dots) mice (R2X = 43%, R2Y = 75%, Q2 = 72%, for the ﬁrst component) (A). Satisfactory cross-validation plot for the PLS-DA model demonstrating a
robust PLS-DA model (B). Changes in a number of metabolites induced by Akt1 activation were found to be consistent across both diet and aging
eﬀects: anserine (C), anserine and carnosine (D), DHA (E), serine (F), phosphate (G), and phosphorylated sugars (H). Peak areas for young controls
(C−G) or young DTG mice (H) from the aging study were normalized to 100 for comparison. (*P < 0.05, ** P < 0.01, and *** P < 0.001.)
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phosphate and serine as well as increased concentrations of
phosphorylated sugars (including glucose-6-phosphate and
mannose-6-phosphate) in the gastrocnemius muscle of the
DTG mice (Figures 2F−H). In addition, GC−FID analysis also
showed a reduction of docosahexaenoic acid (DHA) concen-
tration in the muscle tissues of the DTG mice from the
aging study and the HF/HS-fed DTG mice from the diet study
(Figure 2E). These changes constitute the metabolic signature
associated with Akt1-induced muscle hypertrophy, which are
found consistently across the eﬀects of diet and aging measured
in this study.
Metabolic Perturbation Associated with Akt1-Mediated
Weight Loss
One focus of this study was to elucidate the metabolic
perturbations associated with the Akt1-mediated weight loss in
the HF/HS-induced obese DTG mice. PLS-DA of the NMR
spectra from gastrocnemius muscle showed a clear separation
between the controls and the DTG mice fed the HF/HS diet
(n = 6) after 4 weeks of Akt1 induction (R2X = 48%, R2Y = 93%,
Q2 = 87% for the ﬁrst component). In addition to the above-
mentioned metabolic signatures, the two genotypes fed the HF/
HS diet were further discriminated by signiﬁcantly increased
concentrations of β-hydroxybutyrate, succinate, glycine, and
lactate in the gastrocnemius muscle of the DTG mice. Fur-
thermore, multivariate analysis of GC−MS data also indicated a
perturbation in the TCA cycle, with increased concentrations
of isocitrate, fumarate, and malate found in DTG mice fed the
HF/HS diet (Table 1).
The impact of Akt1 overexpression on the metabolome of
blood serum was then examined. PLS-DA comparing the serum
metabolic proﬁles of the controls and the DTG mice fed a chow
diet failed to produce a multivariate model, indicating that
there were no marked metabolic diﬀerences between these two
groups. However, a robust model was produced comparing both
genotypes fed theHF/HS diet (R2X = 73%,R2Y = 54%,Q2 = 43%
for the ﬁrst PLS-DA component). The serum proﬁle of the HF/
HS-fed DTGmice was characterized by increased concentrations
of β-hydroxybutyrate, lactate, and lipid moieties from both
phospholipids and triglycerides (δ 1.24−1.30, 1.52−1.58, 1.98−
2.06, 2.76−2.84, 4.22−4.28, and 5.28−5.36) (Table 1). In
addition, NMR and GC−MS data highlighted marked reduc-
tions of serum glucose (Figure 3A), fructose, and galactose con-
centrations in the DTG mice. After 4 weeks of Akt1 activation,
the HF/HS-fed DTGmice were highlighted by a >100% increase
in circulatory oleate C18:1 (cis-9), one of themost abundant fatty
acids in serum (Supporting Information Table S1).
Multivariate statistics also indicated that the metabolic impact
of Akt1 induction on the liver metabolome is diet-dependent.
No PLS-DA model was produced comparing both genotypes
fed a chow diet. However, when fed the HF/HS diet, PLS-DA
identiﬁed a number of diﬀerential metabolites, including
increased concentrations of β-hydroxybutyrate, betaine, and
methionine, together with signiﬁcant reductions of lactate,
glucose, galactose, glycogen, alanine, and disaccharides in the
DTG mice (Figure 3B,C and Table 1).
The aging process caused a higher blood glucose concen-
tration in old controls, but this was reduced to a level comparable
to that of young controls following Akt1 activation (Figure 4A).
This metabolic change is most likely associated with increased
muscle glycolysis induced by Akt1 induction, as increased
concentrations of phosphorylated sugars and lactate were also
observed in themuscle of old DTG animals (Figures 2H and 4B).
Consistent with the ﬁndings in the diet study, there are no
signiﬁcant changes in blood glucose and muscle lactate con-
centrations in young animals fed a chow diet, suggesting that
activation of Akt1 expression improved glucose homeostasis in
old animals by restoring its expression to that of young animals.
LC−MS-Based Lipidomics of Gastrocnemius and Liver
Tissue
Chromatograms from extracts from the lipid fraction of liver and
gastrocnemius tissues were collected in positive and negative
ionization mode and processed using multivariate statistics.
Comparisons were made for a single tissue type between diet and
genotype. While no statistically valid model could be built for the
negative ion mode data, dominated by chromatographic peaks
from free fatty acids, robust models could be built for the positive
ion mode data representing chromatographic peaks from
phospholipids and triglycerides.
For the liver tissue data sets, no model could be built com-
paring the control and DTG group on the normal chow diet.
However, robust models were built comparing both the control
animals on chow diet and HF/HS diet (for the PLS-DA model,
R2X = 35%; R2Y = 99%; Q2 = 79%, passed cross-validation by
random permutation test; data not shown) and the DTG animals
on chow diet and HF/HS diet (for the PLS-DA model, R2X =
41%; R2Y = 99%; Q2 = 81%, passed cross-validation by random
permutation test; Figure 5A,B). In both cases, this was driven by
increases in a range of triglycerides in the HF/HS group (for the
DTG group: TAG(51:2), PC(43:0), TAG(51:2), PA(30:0),
TAG(53:2); PA(30:1), TAG(55:10), TAG(50:2), TAG(54:2),
and TAG(53:3)) and a relative reduction of phospholipids (for
the DTG group: lyso-PC(17:1)). In addition, a robust model was
formed between the control mice and the DTG mice on a
HF/HS diet (for the PLS-DA model, R2X = 38%; R2Y = 99%;
Q2 = 66%, passed cross-validation by random permutation test;
Figure 5C). Thismodelwas associatedwith a decrease in triglycerides
Table 1. Summary of Metabolic Changes Detected Following
Analysis by 1H NMR Spectroscopy and GC−MSa
samples increased in DTG mice decreased in DTG mice
gastrocnemius muscle phosphorylated sugars** anserine***
β-hydroxybutyrate* carnosine***
lactate** serine**
glycine*** inorganic phosphate*
succinate**
isocitrate***
fumarate***
malate***
blood serum β-hydroxybutyrate* glucose***
lactate* galactose**
lipid moieties* fructose**
liver tissue β-hydroxybutyrate* glucose**
betaine* galactose*
methionine* disaccharides**
glycogen**
lactate*
alanine**
aComparing gastrocnemius muscle, blood serum, and liver tissue from
the HF/HD-fed controls and DTG mice. P-values were obtained
from Student’s t-test (* P < 0.05, ** P < 0.01, and *** P < 0.001).
The metabolites shown in bold font were found to be consistently
changed across the diet and aging eﬀects.
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and diacylglycerides containing longer, polyunsaturated fatty acids
(TAG (53:4), TAG(56:3), and TAG(57:7)) and an increase in short
chain fatty acids (TAG(48:8), TAG(50:2), TAG(46:4), TAG(48:0),
TAG(47:6), TAG(48:2), and TAG(44:4)) in the DTG group.
Examining the gastrocnemius tissue, no model again could
be built examining the control and DTG mice on chow diet.
However, good models could be built for comparisons of the
control mice on normal chow and HF/HS diets (for the PLS-DA
model, R2X = 37%; R2Y = 99%;Q2 = 88%, passed cross-validation
by random permutation test) and DTG mice on normal chow
and HF/HS diets (for the PLS-DA model, R2X = 36%; R2Y =
99%; Q2 = 78%, passed cross-validation by random permutation
Figure 3. Multiple sections of 1H NMR spectra showing (A) a marked reduction of serum glucose concentration (glucose region: δ 3.22−3.91)
following Akt1 activation in HF/HS-fed mice, (B) an increased hepatic concentration of β-hydroxybutyrate and reductions of lactate and alanine in the
DTGmice, and (C) an increased concentration of betaine and a marked reduction of hepatic glucose concentration (glucose region: δ 3.22−3.92) in the
DTG mice. The NMR spectra were obtained from an individual sample of each class after 4 weeks of Akt1 activation: black spectrum, the HF/HS-fed
controls; red spectrum, the HF/HS-fed DTG mice. Spectra were scaled to the same relative noise level.
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test; Figure 5D,E). While a model could be built that dis-
criminated control and DTGmice on a HF/HS diet, this did not
pass cross-validation.
■ DISCUSSION
The increased prevalence of metabolic syndrome, obesity, and
insulin resistance has led to an increased risk of cardiovascular
disease in the general population.18 Previously, a number of
studies had demonstrated that induction of Akt in the skeletal
muscle of mice induced muscle hypertrophy and caused a
decrease in adipose tissue.6,8,19 The reduction of fat mass
following Akt1 activation was associated with enhanced lipolysis
in the adipose tissue as well as an increased fatty acid oxidation in
the liver.6 These animals also exhibited improved metabolic
parameters, including improved insulin sensitivity and reduc-
tions in blood glucose and leptin concentrations.
In the current study, metabolomic analysis associated Akt1
activation in mouse muscle tissue with profound metabolic
perturbations in the liver, blood serum, and gastrocnemius
muscle, particularly when the animals were fed a HF/HS diet
(Figure 6). Notably, the HF/HS-fed DTG mice demonstrated
reduced blood glucose as well as increased circulatory lactate
concentration, suggesting upregulation of glycolysis following
Akt1 induction in the skeletal muscle. Indeed, the examination of
the metabolic composition of muscle highlighted markedly
increased concentrations of glycolytic metabolites including
phosphorylated sugars and lactate. This is consistent with
previous ﬁndings showing increased glucose uptake and the
upregulation of glycolytic genes in these animals.6 The lactate
produced via anaerobic glycolysis in muscle is transported to
the liver and then metabolized to produce glucose through
gluconeogenesis as part of the Cori cycle. Metabolic proﬁling of
the liver indicated reduced lactate, alanine, and glycogen,
suggesting that the liver had increased gluconeogenesis and
glycogenolysis to replenish glucose stores in muscle. This cross-
talk between muscle and liver enables muscle to shift its energy
burden to the liver and at the same time reduce the eﬀects of
high-fat/high-sucrose feeding.
Intriguingly, the increased gluconeogenesis and glycogenolysis
also stimulated fatty acid oxidation, with increased concen-
trations of β-hydroxybutyrate in the blood. Protein synthesis is
an energy-expensive process. In the DTG mice, there was a
consistent increase in the concentration of β-hydroxybutyrate in
the liver, blood serum, and gastrocnemius muscle, particularly
when the mice were fed the HF/HS diet. β-Hydroxybutyrate is a
ketone body that is produced in the liver through ketogenesis
following fatty acid oxidation. In extrahepatic tissues, it can be
utilized as a fuel, being metabolized through the TCA cycle,
especially during prolonged fasting or starvation.
It is known that Akt1 activation speciﬁcally induces growth of
type IIb muscle ﬁbers, also known as fast/glycolytic muscle.6
This muscle has a lower density of mitochondria and therefore is
less dependent on the TCA cycle and β-oxidation. Nevertheless,
the current data demonstrated that the continuous supply
of substrates in the form of ketone bodies, glucose, and possibly
fatty acids led to increased concentrations of TCA cycle
intermediates, including isocitrate, succinate, fumarate, and
malate, in the gastrocnemius muscle of the HF/HS-fed DTG
animals. This process, which involves cross-talk among muscle,
liver, and adipose tissue, could serve as a supplementary energy
source in addition to glycolysis for the enhanced protein
synthesis needed for muscle hypertrophy.
Metabolic proﬁling of gastrocnemius muscle revealed a
number of diﬀerential metabolites that consistently discrimi-
nated the controls and DTG mice. In the DTG mice, Akt1-
induced muscle hypertrophy was associated with decreased
concentrations of anserine, carnosine, inorganic phosphate,
serine, and DHA, as well as increased concentrations of
phosphorylated sugars in the muscle.
Among these metabolic changes, anserine and carnosine are of
particular interest as they were previously reported to regulate
the energy-producing pathway in proliferative tumor cells.20,21
Carnosine (β-alanyl-L-histidine) and its methylated derivative,
anserine (β-alanyl-1-methyl-L-histidine), are natural occurring
histidine-containing dipeptides, which are present in many
vertebrate tissues, predominantly in skeletal muscle and brain.22
Anserine is found to be absent from human tissues despite a high
concentration of carnosine (20 mM) in skeletal muscle.23
Accumulating evidence shows that both of these dipeptides share
similar structure and exhibit similar biological functions
including antioxidant, pH buﬀering, and antiglycosylation
activities, as well as metal ion chelation.22,24 In the absence of
pyruvate, carnosine and anserine are cytotoxic to transformed or
tumor cells, but not to normal cells.20 Recently, carnosine was
found to inhibit ATP production through anaerobic glycolysis in
cells from malignant glioma.21 In addition, it also retards tumor
growth in the N1H3T3-HER2/neu mouse model and inhibits
high-glucose-induced mesangial cell proliferation.25,26
Increased Akt1 activity is evident in numerous cancers and
proliferative cells.27−29 In the current study, signiﬁcant reduc-
tions of anserine and carnosine were associated with an upregulation
Figure 4. Increased blood glucose concentration associated with
aging was reduced by Akt1 induction (A). This may be associated with
increased glycolysis, as an increased concentration of lactate was
detected in the hypertrophic muscle of the DTG animals (B).
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in anaerobic glycolysis in gastrocnemius muscle of DTG mice.
Indeed, when the mice were fed the HF/HS diet, the con-
centrations of these histidine-containing dipeptides were found
to be negatively correlated with the lactate concentration in the
gastrocnemius muscle (Figure 7). Taken together, the current
ﬁndings suggest a similar regulatory role of these dipeptides on
energy metabolism in Akt1-induced hypertrophic muscle and
tumor cells, which both experience active cell growth and depend
on ATP obtained from glycolysis.
In addition to the metabolic advantage of Akt1 induction in
regulating fat accumulation induced by both diet and aging, the
current study also demonstrated the beneﬁcial eﬀect of Akt1 in
glucose homeostasis. In mice fed a HF/HS diet, the circulatory
glucose concentration was reduced following Akt1 activation.
Similarly, Akt1 activation was also found to reduce the increase in
glucose concentration caused by aging in old animals. These
results suggest an underappreciated role of Akt1 in regulating
glucose metabolism.
Previously, we have shown that muscle-speciﬁc overexpression
of Akt1 in the DTG mice led to an increase in circulating
ﬁbroblast growth factor 21 (FGF-21).30 In fact, a number of
metabolic perturbations observed in the current study could be
associated with the metabolic role of FGF-21. FGF-21 is known
to be induced by fasting and is associated with upregulated
hepatic fatty acid oxidation and ketogenesis and improvement
in hepatic steatosis.31 Correspondingly, in our study, the con-
centration of β-hydroxybutyrate was found to be signiﬁcantly
increased in liver, blood serum, and gastrocnemius muscle of the
DTG mice, especially when the mice were fed the HF/HS diet.
This was also apparent in the LC−MS data sets from the liver
tissue. While HF/HS feeding increased a range of triglycerides
in the liver for both the control and DTG mice compared with
animals on the chow diet, the induction of AKT led to a
remodeling of the lipid species present in the liver with a
reduction in longer chain polyunsaturated fatty acids and a
relative increase in shorter fatty acids. Long chain polyunsatu-
rated fatty acids are largely dietary derived, while short chain,
Figure 5. PLS-DA scores plot of the LC−MS lipidomic data of liver tissue show separation between DTG mice fed the chow and HF/HS diets (A).
Satisfactory cross-validation plot for the PLS-DA model demonstrating a robust PLS-DA model (B). Group separation was also observed between
controls and the DTGmice fed with the HF/HS diet (C). PLS-DA scores plot of the LC−MS lipidomic data of gastrocnemius tissue showed separation
between DTG mice fed the chow and HF/HS diets (D); the model passed cross-validation by random permutation test (E).
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predominantly saturated, fatty acids can be synthesized in the
liver from carbohydrate via de novo lipogenesis. Thus, in the
DTG mice, it would appear that induction of AKT increases
the oxidation of dietary derived fatty acids systemically and also
stimulates the conversion of carbohydrate into shorter chain fatty
acids in the liver. Intriguingly, these changes were less apparent in
skeletal muscle, suggesting that a major part of the beneﬁcial
eﬀect of AKT induction in skeletal muscle was initiated in the
liver.
Tyynismaa and colleagues demonstrated that mitochondrial
myopathy in skeletal muscle led to activation of Akt1 and
induction of FGF-21.32 In this study, the mice with late-onset
mitochondrial myopathy exhibited smaller adipocytes and lower
hepatic fat content and were resistant to weight gain on the high-
fat diet. Collectively, these studies suggest that skeletal muscle
could initiate molecular signaling and orchestrate systemic
metabolic changes to reduce obesity.
■ CONCLUSIONS
In summary, a combination of 1H NMR spectroscopy, GC−MS,
GC−FID, and LC−MS was used to examine the metabolomic
proﬁles of a conditional transgenic mouse model that speciﬁcally
overexpresses the Akt1 gene in skeletal muscle. Our data indicate
that Akt1 activation induced metabolic perturbations including
upregulated anaerobic glycolysis in the gastrocnemius muscle as
well as increased gluconeogenesis, glycogenolysis, and keto-
genesis in the liver. These processes demonstrated how muscle
hypertrophy can alter systemic metabolism, inﬂuencing distant
organs, to supply nutrients required for myogenic cell growth
and at the same time limit diet-induced obesity. Taken together,
the current study highlights the metabolic role of glycolytic
muscle ﬁbers, which can be induced by resistance exercise, in
regressing diet-induced obesity and age-related fat accumulation
and improving glucose metabolism.
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Figure 6. Profound metabolic perturbation as a result of Akt1 induction
in the skeletal muscle of the HF/HS-fed DTG mice (red, increase in
concentration; blue, decrease in concentration) as compared with the
controls fed the same diet. Increased Cori cycle activity and hepatic fatty
acid oxidation were evident in the DTG mice. Abbreviations: α-KG,
α-ketoglutarate; β-HB, β-hydroxybutyrate; DMG, dimethylglycine;
G6P, glucose-6-phosphate; M6P, mannose-6-phosphate.
Figure 7. For the HF/HS-fed animals, the concentrations of anserine and carnosine were negatively correlated with the lactate concentration in the
gastrocnemius muscle (Pearson correlation coeﬃcient, r = −0.90). A weaker correlation was observed when all data from both diet and aging studies
were considered (r = −0.63).
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